Dr Reddy's Laboratories Limited
Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%
The stock gained 9 per cent in two days after the pharma company reported better-than-expected revenue growth in March quarter (Q4FY22).
 "Dr Reddy's sees sharpest intra-day rally since Sept 2020; stock surges 8%")
Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose
Dr Reddy's Laboratories is hoping to go to a regulator for its single-dose Sputnik Light jab as booster dose for approvals by June-end or early July, a senior official said
 "Dr Reddy's Lab to approach regulator for Sputnik Light as booster dose")
75% of Nifty50 stocks trade below 200-DMA; look weak on the charts
Tech Mahindra and Wipro have tumbled over 30 per cent, while Apollo Hospitals Enterprise and Dr. Reddy's Laboratories have plummeted 22 per cent so far in calendar year 2022 (CY22)
 "75% of Nifty50 stocks trade below 200-DMA; look weak on the charts")
Stocks to Watch: Mahindra CIE, Dilip Buildcon, SIS, Butterfly Gandhimathi
Stocks like Sun Pharma, Dr.Reddy's and others having exposure to Europe are likel to be in focus as the Russia-Ukraine crisis deepens.
 "Stocks to Watch: Mahindra CIE, Dilip Buildcon, SIS, Butterfly Gandhimathi")
Dr Reddy's Laboratories inks exclusive sales pact with Novartis India
Dr Reddy's Laboratories has entered into an exclusive sales and distribution agreement with Novartis India Ltd (NIL), a statement said
 "Dr Reddy's Laboratories inks exclusive sales pact with Novartis India")
Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly
The Hyderabad-based firm said it will introduce the drug under the brand name Molflu in India
 "Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly")
Sensex, Nifty end flat; Star Health settles at issue price; PSBs shine
The broader markets outperformed, the BSE Midcap and Smallcap indices were up 0.3 per cent and 0.8 per cent, respectively
 "Sensex, Nifty end flat; Star Health settles at issue price; PSBs shine")
Covid: Dr Reddy's eyes Sputnik vaccine exports after domestic struggle
Now, Dr Reddy's is focusing on the single-dose Sputnik Light, as a booster shot or standalone, instead of the two-dose Sputnik V, a spokesperson said
 "Covid: Dr Reddy's eyes Sputnik vaccine exports after domestic struggle")
BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%
The pharma index had taken a breather over the past three months after displaying relative out-performance during CY20-21.
 "BSE Healthcare index up 2%; Cipla, Alkem, Dr.Reddy's rally up to 8%")
Without innovation Indian pharma cannot touch $130 bn by 2030: Industry
Sun Pharma says it eyes $1.5 bn from innovative products in 3-4 years
 "Without innovation Indian pharma cannot touch $130 bn by 2030: Industry")
Fag-end buying in IT, banks lifts Sensex 831 pts at 60,138, Nifty at 17,930
The broader markets also logged strong gains, with the Midcap index up 1.8 per cent and the Smallcap index adding up 1.1 per cent
 "Fag-end buying in IT, banks lifts Sensex 831 pts at 60,138, Nifty at 17,930")
Dr Reddy's Laboratories working on enhancing Covid-19 portfolio
As for MSD's drug Molnupiravir, which is currently undergoing clinical trial in India, the company said it has already shared interim data with the drug regulator
Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
Dr Reddy's global generic business grew 19 per cent YoY to Rs 4,743 crore driven by covid portfolio, new product launches and base business volume traction across key markets.
 "Dr Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand")
Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule
Dr Reddy's Laboratories on Tuesday said it has received approval from the US health regulator to market Lenalidomide capsules
 "Dr Reddy's Lab receives USFDA approval to market Lenalidomide capsule")
Dr Reddy's Laboratories, Zydus Pharma recall products in US market
Dr Reddy's Laboratories, Inc, the US arm of Dr Reddy's Laboratories, is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg
India's worst-performing stock in July may rebound if history is any guide
Shares of pharma firm Dr Reddy's Labs have rallied about 15% after losing steam
 "India's worst-performing stock in July may rebound if history is any guide")
DRDO to get 2% royalty from Dr Reddy's on sale of Covid drug 2-DG in India
The drug comes in powder form in sachet and is taken orally by dissolving it in water.
Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months
Alembic Pharma and Dr Reddy's Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results
 "Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months")
Sputnik V soft launched in over 50 cities in India: Dr Reddy's Laboratories
Dr Reddys Laboratories Ltd, which soft-launched Russia's Covid-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country
 "Sputnik V soft launched in over 50 cities in India: Dr Reddy's Laboratories")
Sputnik V second dose shortage to delay India's full rollout: Dr Reddy's
Dr. Reddy's had received about 3 million first doses by June 1 and about 360,000 doses of the second by early this month, the company and the Indian government have said
